Cardiac preconditioning by anesthetic agents: Roles of volatile anesthetics and opioids in cardioprotection

Yonago Acta Medica

Volumn 50, Issue 3, 2007, Pages 45-55

  Inagaki, Yoshimi ^a  

^a TOTTORI UNIVERSITY   (Japan)

Author keywords

ATP sensitive potassium channel; Ischemic preconditioning; Opioid; Pharmacological preconditioning; Volatile anesthetic

Indexed keywords

1,2,3,4,4A,5,12,12AALPHA OCTAHYDRO 4AALPHA (3 HYDROXYPHENYL) 2 METHYLQUINOLINO[2,3 G]ISOQUINOLINE; 8 (4 SULFOPHENYL)THEOPHYLLINE; 8 CYCLOPHENYL 1,3 DIPROPYLXANTHINE; ADENOSINE RECEPTOR; ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; CHELERYTHRINE; DELTA OPIATE RECEPTOR; DESFLURANE; DIAZOXIDE; ENFRURANE; ENKEPHALIN[2 DEXTRO ALANINE 5 DEXTRO LEUCINE]; FENTANYL; G PROTEIN COUPLED RECEPTOR; HALOTHANE; INHALATION ANESTHETIC AGENT; ISOFLURANE; KAPPA OPIATE RECEPTOR; MORPHINE; N ACETYL S NITROSOPENICILLAMINE; NALOXONE; NICORANDIL; NITRIC OXIDE; OPIATE; OXYGEN RADICAL; PROTEIN KINASE; PROTEIN KINASE C; REMIFENTANIL; SEVOFLURANE; UNCLASSIFIED DRUG; UNINDEXED DRUG; XANTHINE DERIVATIVE;

ANESTHESIA; CALCIUM CELL LEVEL; CELL PROTECTION; CYTOSOL; DRUG EFFICACY; DRUG MECHANISM; HEART INFARCTION; HEART INFARCTION PREVENTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; HUMAN; ISCHEMIC PRECONDITIONING; MITOCHONDRION; NONHUMAN; PHARMACODYNAMICS; REPERFUSION INJURY; REVIEW; SIGNAL TRANSDUCTION;

EID: 35848949778     PISSN: 05135710     EISSN: 13468049     Source Type: Journal    
DOI: None     Document Type: Review

References (70)

1. Akao M, Ohler A, O'Rourke B, Marban E. Mitocondorial ATP-sensitive potassium channels inhibit apoptosis induced by oxidative stress in cardiac cells. Circ Res 2001;88:1267-1275.
2. 2+ responses in intact hearts. Am J Physiol Heart Circ Physiol 2001;281:H1508-H1523.
3. Bell SP, Sack MN, Patel A, Opie LH, Yellon DM. Delta opioid receptor stimulation mimics ischemic preconditioning in human heart muscle. J Am Coll Cardiol 2000;36:2296-2302.
4. + channels in rabbit heart. Am J Physiol 1999;277:H128-H135.
5. Bolli R, Marban E. Molecular and cellular mechanisms of myocardial stunning. Physiol Rev 1999;79:609-634.
6. Bolli R. Cardioprotective function of inducible nitric oxide synthase and role of nitric oxide in myocardial ischemia and preconditioning: an overview of a decade of research. J Mol Cell Cardiol 2001;33:1897-18918.
7. Braunwald E, Kloner RA. The stunned myocardium: prolonged, postischemic ventricular dysfunction. Circulation 1982;66:1146-1149.
8. Chien GL, Mohtadi K, Wolff RA, Van Winkle DM. Naloxone blockade of myocardial ischemic preconditioning does not require central nervous system participation. Basic Res Cardiol 1999;94:136-143.
9. ATP channels. Circ Res 2001;89:273-278.
10. Cope DK, Impastato WK, Cohen MV, Downey JM. Volatile anesthetics protect the ischemic rabbit myocardium from infarction. Anesthesiology 1997;86:699-709.
11. Fobes RA, Steenbergen C, Murphy E. Diazoxide-induced cardioprotection requires signaling through a redox-sensitive mechanism. Circ Res 2001;88:802-809.
12. ATP channels. Circ Res 1999;84:846-851.
13. + cycle. Biochim Biophys Acta 2003;1606:23-41.
14. Guo Y, Jones WK, Xuan YT, Tang XL, Bao W, Wu WJ, et al. The late phase of ischemic preconditioning is abrogated by targeted disruption of the inducible NO synthase gene. Proc Natl Acad Sci USA 1999;96:11507-11512.
15. Hanouz J, Yvon A, Massetti M, Lepage O, Babatasi G, Khayat A, et al. Mechanisms of desflurane-induced preconditioning in isolated human right atria in vitro. Anesthesiology 2002;97:33-41.
16. Hanouz JL, Massetti M, Guesne G, Chanel S, Babatasi G, Rouet R, et al. In vitro effects of desflurane, sevoflurane, isoflurane, and halothane in isolated human right atria. Anesthesiology 2000;92:116-124.
17. Hara T, Tomiyasu S, Sungsam C, Fukusaki M, Sumikawa K. Sevoflurane protects stunned myocardium through activation of mitochondrial ATP-sensitive potassium channels. Anesth Analg 2001;92:1139-1145.
18. Heindl B, Reichle FM, Zahler S, Conzen PF, Becker BF. Sevoflurane and isoflurane protect the reperfused guinea pig heart by reducing postischemic adhesion of polymorphonuclear neutrophils. Anesthesiology 1999a;91:521-530.
19. Heindl B, Becker BF, Zahler S, Conzen PF. Volatile anaesthetics reduce adhesion of blood platelets under low-flow conditions in the coronary system of isolated guinea pig heart. Acta Anaesthesiol Scand 1998;42:995-1003.
20. Heindl B, Conzen PF, Becker BF. The volatile anesthetic sevoflurane mitigates cardiodepressive effects of platelets in reperfused hearts. Basic Res Cardiol 1999b;94:102-111.
21. Holmuhamedov EL, Jovanovic S, Dzeja PP, Jovanovic A, Terzic A. Mitochondrial ATP-sensitive potassium channels modulate cardiac mitochondrial function. Am J Physiol 1998;275:H567-H576.
22. ATP channels. Am J Physiol 2001;280:H377-H383.
23. Jaffe JH, Martin WR. Opioid analgesics and antagonists. In: Goodman Gillman A, Rall TW, Nies AS, Taylor P, eds. The pharmacological basis of therapeutics, 8th ed. New York: Pergamon Press; 1990. p. 485-521.
24. Jordan JE, Zhao ZQ, Vinten-Johansen J. The role of neutrophils in myocardial ischemia-reperfusion injury. Cardiovasc Res 1999;43:860-878.
25. Kawamura S, Yoshida K, Miura T, Mizukami Y, Matsuzaki M. Ischemic preconditioning translocates PKC-δ and -ε, which mediate functional protection in isolated rat heart. Am J Physiol 1998;275:H2266-H2271.
26. Kersten J, Orth KG, Pagel PS, Mei DA, Gross GJ, Warltier DC. Role of adenosine in isoflurane-induced cardioprotection. Anesthesiology 1997;86:1128-1139.
27. Kowalski C, Zahler S, Becker BF, Flaucher A, Conzen PF, Gerlach E, et al. Halothane, isoflurane, and sevoflurane reduce postischemic adhesion of neutrophils in coronary system. Anesthesiology 1997;86:188-195.
28. + channel of the heart mitochondria. Am J Physiol Heart Circ Physiol 2001;280:H649-H657.
29. Laclau MN, Boudina S, Thambo JB, Tariosse L, Gouverneur G, Bonoron-Adele S, et al. Cardioprotection by ischemic preconditioning preserves mitochondrial function and functional coupling between adenine nucleotide translocase and creatine kinase. J Mol Cell Cardiol 2001;33:947-956.
30. Li G, Chen S, Lu E, Li Y. Ischemic preconditioning improves preservation with cold blood cardioplegia in valve replacement patients. Eur J Cardiothorac Surg 1999;15:653-657.
31. ATP channels. Circ Res 1999;84:1396-1400.
32. Light PE, Bladen C, Winkfein RJ, Walsh MP, French RJ. Molecular basis of protein kinase C-induced activation of ATP-sensitive potassium channels. Proc Natl Acad Sci USA 2000;97:9058-9063.
33. Lochner A, Harper IS, Salie R, Genade S, Coetzee AR. Halothane protects the isolated rat myocardium against excessive total intracellular calcium and structural damage during ischemia and reperfusion. Anesth Analg 1994;79:226-233.
34. Lu EX, Chen SX, Hu TH, Xui LM, Yuan MD. Preconditioning enhances myocardial protection in patients undergoing open heart surgery. J Thorac Cardiovasc Surg 1998;46:28-32.
35. Mattheussen M, Rusy BE, Van Aken H, Flameng W. Recovery of function and adenosine triphosphate metabolism following myocardial ischemia induced in the presence of volatile anesthetics. Anesth Analg 1993;76:69-75.
36. Maxwell SRJ, Lip GYH. Reperfusion injury: a review of the pathophysiology, clinical manifestations and therapeutic options. Int J Cardiol 1997;58:95-117.
37. McPherson BC, Yao Z. Signal transduction of opioid-induced cardioprotection in ischemia-reperfusion. Anesthesiology 2001;94:1082-1088.
38. Möbert J, Zahler S, Becker BF, Conzen PF. Inhibition of neutrophil activation by volatile anesthetics decreases adhesion to cultured human endothelial cells. Anesthesiology 1999;90:1372-1381.
39. Müllenheim J, Ebel D, Fräßdorf J, Preckel B, Thämer V, Schlack W. Isoflurane preconditions myocardium against infarction via release of free radicals. Anesthesiology 2002;96:934-940.
40. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986;74:1124-1136.
41. Nakano A, Cohen MV, Downey JM. Ischemic preconditioning. From basic mechanisms to clinical applications. Pharmacol Ther 2000;86:263-275.
42. Ninomiya H, Otani H, Lu K, Uchiyama T, Kido M, Imamura H. Enhanced IPC by activation of pertussis toxin-sensitive and -insensitive G protein-coupled purinoceptors. Am J Physiol Heart Circ Physiol 2002;282:H1933-H1943.
43. Novalija E, Stowe DF. Prior preconditioning by ischemia or sevoflurane improves cardiac work per oxygen use in isolated guinea pig hearts after global ischemia. Adv Exp Med Biol 1998;454:533-542.
44. Novalija E, Fujita S, Kampine JP, Stowe DF. Sevoflurane mimics ischemic preconditioning effects on coronary flow and nitric oxide release in isolated hearts. Anesthesiology 1999;91:701-712
45. Okubo S, Xi L, Bernardo NL, Yoshida K, Kukreja RC. Myocardial preconditioning: basic concepts and potential mechanisms. Mol Cell Biochem 1999;196:3-12.
46. Opie LH. Cell death: myocardial infarction. In: Opie LH, ed. The heart. Physiology, from cell to circulation, 3rd ed. Philadelphia: Lippincott-Raven Publishers; 1998a. p. 543-561.
47. Opie LH. Oxygen lack: ischemia and angina. In: Opie LH, ed. The heart. Physiology, from cell to circulation, 3rd ed. Philadelphia: Lippincott-Raven Publishers; 1998b. p. 515-541.
48. Opie LH. Myocardial reperfusion: new ischemic syndromes. In: Opie LH, ed. The heart. Physiology, from cell to circulation, 3rd ed. Philadelphia: Lippincott-Raven Publishers; 1998c. p. 563-588.
49. Piriou V, Ross S, Pigott D, Evans R, Foex P. Beneficial effects of concomitant administration of isoflurane and nicorandil. Br J Anaesth 1997;79:68-77.
50. Rubino A, Yellon DM. Ischemic preconditioning of the vasculature: an overlooked phenomenon for protecting the heart? Trends Pharmacol Sci 2000;21:225-230.
51. ATP channels in cardiac myocytes. Am J Physiol Heart Circ Physiol 2001;280:H1882-H1888.
52. Sato T, Sasaki N, O'Rourke B, Marban E. Adenosine primes the opening of mitochondrial ATP-sensitive potassium channels: a key step in ischemic preconditioning? Circulation 2000;102:800-805.
53. Schultz JEJ, Gross GJ. Opioids and cardioprotection. Pharmacol Ther 2001;89:123-137.
54. Shimizu J, Sakamoto A, Ogawa R. Activation of the adenosine triphosphate sensitive mitochondrial potassium channel is involved in the cardioprotective effect of isoflurane. J Nippon Med Sch 2001;68:238-245.
55. Strasser RH, Braun-Dullaeus R, Waldendzik H, Maruetant R. Alpha 1-receptor-independent activation of protein kinase C in acute myocardial ischemia: mechanisms for sensitization of the adenyl cyclase system. Circ Res 1992;70:1304-1312.
56. Szmagala P, Morawski W, Krejca M, Gburek T, Bochenek A. Evaluation of perioperative myocardial tissue damage in ischemically preconditioned human heart during aortocoronary bypass surgery. J Cardiovasc Surg (Torino) 1998;39:791-795.
57. Tomai F, Crea F, Chiariello L, Gioffre PA. Ischemic preconditioning in humans. Models, mediators, and clinical relevance. Circulation 1999a;100:559-563.
58. Tomai F, Crea F, Gaspardone A. Effects of naloxaone on myocardial ischemic preconditioning in humans. J Am Coll Cardiol 1999b;33:1863-1869.
59. ATP channels in adenosine-enhanced ischemic preconditioning. Am J Physiol Heart Circ Physiol 2000;279:H2694-H2703.
60. Toller WG, Montgomery MW, Pagel PS, Hettrick DA, Warltier DC, Kersten JR. Isoflurane-enhanced recovery of canine stunned myocardium: role for protein kinase C? Anesthesiology 1999a;91:713-722.
61. Toller WG, Kersten JR, Pagel PS, Hettrick DA, Warltier DC. Sevoflurane reduces myocardial infarct size and decreases the time threshold for ischemic preconditioning in dogs. Anesthesiology 1999b;91:1437-1446.
62. Tol ler WG, Kersten J R, G ross ER, Pagel PS, Warltier DC. Isoflurane preconditions myocardium against infarction via activation of inhibitory guanine nucleotide binding proteins. Anesthesiology 2000a;92:1400-1407.
63. Toller WG, Gross ER, Kersten JR, Pagel PS, Gross GJ, Warltier DC. Sarcolemmmal and mitochondrial adenosine triphosphate-dependent potassium channels. Mechanism of desflurane-induced cardioprotection. Anesthesiology 2000b;92:1731-1739.
64. Vahlhaus C, Schulz R, Post H, Onallah R, Heusch G. No prevention of ischemic preconditioning by the protein kinase C inhibitor staurosporine in swine. Circ Res 1996;79:407-414.
65. ATP channels. Am J Physiol Heart Circ Physiol 2001;280:H2321-H2328.
66. Warltier DC, al Wathiui MH, Kampine JP, Schmeling WT. Recovery of contractile function of stunned myocardium in chronically instrumented dogs is enhanced by halothane or isoflurane. Anesthesiology 1988;69:552-565.
67. Zang Y, Irwin MB, Wong TM. Remifentanil preconditioning protects against ischemic injury in the intact rat heart. Anesthesiology 2004;101:918-925.
68. Zang Y, Irwin MB, Wong TM, Chen M, Cao CM. Remifentanil preconditioning confers cardioprotection via cardiac - and -opioid receptors. Anesthesiology 2005;102:371-378.
69. ATP channels via multiple signaling pathways. Anesthesiology 2002;97:4-14.
70. Zaugg M, Lucchinetti E, Uecker M, Pasch T, Schaub MC. Anaesthetics and preconditioning. Part I. Signalling and cytoprotective mechanisms. Br J Anaesth 2003;91:551-565.